Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia

Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia

Abstract INTRODUCTION Brain‐derived tau (BD‐tau) measures tau specifically from brain‐derived sources and can differentiate Alzheimer's disease (AD) from other diseases. This study investigated BD‐tau as a potential biomarker of treatment effect. METHODS BD‐tau and phosphorylated tau‐217 (p‐tau...

Full description

Saved in:
Bibliographic Details
Main Authors: Cassandra Marotta, Fernando Gonzalez‐Ortiz, Michael Turton, Henrik Zetterberg, Peter Harrison, Christopher M. Hovens, Benjamin Sinclair, Terence J. O'Brien, Kaj Blennow, Lucy Vivash
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Alzheimer's disease
anti‐tau treatment
behavioral variant frontotemporal dementia
brain‐derived tau
fluid biomarkers
treatment effect
Online Access:https://doi.org/10.1002/dad2.70123
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/dad2.70123

Similar Items